Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)

• Xuerong Wen ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing

  * E-mail: xuerongwen@uri.edu

  Affiliation Health Outcomes, Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, United States of America

  https://orcid.org/0000-0002-4803-7895

  ⨯
• Shuang Wang,

  Roles Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Health Outcomes, Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, United States of America

  ⨯
• Tracey H. Taveira,

  Roles Conceptualization, Investigation, Methodology, Writing – review & editing

  Affiliations Health Outcomes, Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, United States of America, Cardiovascular Department, Providence Veterans Affairs Medical Center, Providence, RI, United States of America, Warren Alpert School of Medicine, Brown University, Providence, RI, United States of America

  ⨯
• Fatemeh Akhlaghi

  Roles Conceptualization, Investigation, Methodology, Resources, Supervision, Writing – review & editing

  Affiliation Clinical Pharmacokinetics Research Laboratory, Department of Biomedical and Pharmaceutical Science, College of Pharmacy, University of Rhode Island, Kingston, RI, United States of America

  ⨯